Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (51)

2023

  1. Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis

    Computer Methods and Programs in Biomedicine, Vol. 242

2022

  1. A Tool to Distinguish Viral from Bacterial Pneumonia

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 1, pp. 31-36

  2. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  3. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. Prevalence of thrombotic complications in children with SARS-CoV-2

    Archives of Disease in Childhood, Vol. 106, Núm. 11, pp. 1129-1132

  2. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain

    JAMA Pediatrics

2020

  1. Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics

    Anales de Pediatria, Vol. 92, Núm. 4, pp. 239-240

2019

  1. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study

    Vaccine, Vol. 37, Núm. 16, pp. 2200-2207

  2. Multiple liver abscesses in Crohn’s disease in infliximab therapy, successfully treated with antibiotic therapy

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 6, pp. 566-568

  3. Oseltamivir for the treatment of influenza in children and adolescents

    Anales de Pediatria, Vol. 90, Núm. 5, pp. 317.e1-317.e8

2018

  1. Hyponatremia in children with pneumonia rarely means SIADH

    Paediatrics and Child Health (Canada), Vol. 23, Núm. 7, pp. E126-E133

2017

  1. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

    Journal of Pediatrics, Vol. 185, pp. 117-123.e6

  2. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children

    Vaccine, Vol. 35, Núm. 35, pp. 4646-4651

2016

  1. Bacteremic Pneumonia before and after Withdrawal of 13-Valent Pneumococcal Conjugate Vaccine from a Public Vaccination Program in Spain: A Case-Control Study

    Journal of Pediatrics, Vol. 171, pp. 111-115.e3

  2. Complications of pneumococcal bacteremia after thirteen-valent conjugate vaccine withdrawal

    Pediatric Infectious Disease Journal, Vol. 35, Núm. 12, pp. 1281-1287

2015

  1. Hemophagocytic Lymphohistiocytosis in Children with Visceral Leishmaniasis

    Pediatric Infectious Disease Journal, Vol. 34, Núm. 6, pp. 667-669

2013

  1. Expansion of serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain

    Clinical and Vaccine Immunology, Vol. 20, Núm. 10, pp. 1524-1530

  2. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011

    Pediatric Infectious Disease Journal

  3. Infective endocarditis in congenital heart disease: A frequent community-acquired complication

    Infection, Vol. 41, Núm. 1, pp. 167-174

  4. Oseltamivir treatment for influenza in hospitalized children without underlying diseases

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 10, pp. 1066-1069